trial · primary record
Tofacitinib 5 MG BID
Glucocorticoid Resistant ICIs-related Myocarditis
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 25 |
| Primary completion | 2025-12-16 |
| Primary endpoint | All-cause mortality within three months |
| Registry ID | NCT06393972 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:34.940Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06393972
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.